当前位置：药药网 / 医药文献 /制药提价与抑制仿制药方式(本栏目收费,不能显示细节,电话13136136841)
关键字：
类型：
下载页码(大于1,小于132)：
制药提价与抑制仿制药方式 472条(本栏目收费,不能显示细节,电话13136136841)
of both the brand- name drug company and
the generic company are aligned with each
other ,but not with society’s interests, 36
36
pediatric HoFN, 109, 112
109 112
pediatric homozygous familial
hypercholesterolemia. See pediatric HoFN
Abilify and, 110,12
110 12
In re Lipitor case of, 53,56
53 56
pharmaceutical companies. See brand- name drug
companies; by individual company
pharmaceutical economics, 13,19
13 19
pharmaceutical pricing and costs, 7
7
benefits of despite high prices and regulatory abuse, 12
12
concern and protest over rising costs of at J.P.
Morgan Healthcare Conference (2016), 2, 4
2 4
Daraprim of Turing Pharmaceuticals and, 3
3
defense of rising costs at J.P. Morgan
Healthcare Conference (2016), 6,7
6 7
effect of Big Pharma’s blocking of generic competition on, 9
9
generic competition effect on brand name drugs, 7
7
generics and, 20,21
20 21
increased drug prices via pay- for- delay, 38
38
Obama on rising costs of prescription medication, 5
5
overview of complexity of pharmaceutical economics, 13,19
13 19
pharma companies perspective on, 7
7
protests over Sovaldi pricing (hepatitis C drug,Gilead), 2
2